Sutent + Taxol for Advanced Esophageal Cancer

NCT00730353 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Sunitinib malate
DRUG: Paclitaxel

Sponsor

Hoosier Cancer Research Network

Collaborators

[object Object]